BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17890186)

  • 1. Modelling transdermal delivery of high molecular weight drugs from microneedle systems.
    Al-Qallaf B; Das DB; Mori D; Cui Z
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2951-67. PubMed ID: 17890186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y; Xu B; Gao Y
    Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of MEMS microneedles.
    Teo MA; Shearwood C; Ng KC; Lu J; Moochhala S
    Biomed Microdevices; 2005 Mar; 7(1):47-52. PubMed ID: 15834520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration.
    Sivamani RK; Stoeber B; Wu GC; Zhai H; Liepmann D; Maibach H
    Skin Res Technol; 2005 May; 11(2):152-6. PubMed ID: 15807814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays.
    van der Maaden K; Luttge R; Vos PJ; Bouwstra J; Kersten G; Ploemen I
    Drug Deliv Transl Res; 2015 Aug; 5(4):397-406. PubMed ID: 26044672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.
    Verbaan FJ; Bal SM; van den Berg DJ; Groenink WH; Verpoorten H; Lüttge R; Bouwstra JA
    J Control Release; 2007 Feb; 117(2):238-45. PubMed ID: 17196697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle mediated delivery of nanoparticles into human skin.
    Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
    Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method.
    Verbaan FJ; Bal SM; van den Berg DJ; Dijksman JA; van Hecke M; Verpoorten H; van den Berg A; Luttge R; Bouwstra JA
    J Control Release; 2008 May; 128(1):80-8. PubMed ID: 18394741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force.
    Davis SP; Landis BJ; Adams ZH; Allen MG; Prausnitz MR
    J Biomech; 2004 Aug; 37(8):1155-63. PubMed ID: 15212920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.